-
October 1, 2005PREVIEW
The first in a new class of drugs, the costimulation modulators, could be approved for treatment of rheumatoid arthritis by FDA by year’s end, and another agent in the class is in the final...
-
May 1, 2005PREVIEW
Following last month’s removal of valdecoxib (Bextra—Pfizer) from the U.S. market, few choices remain for GI-sensitive patients requiring long-term treatment with NSAIDs for conditions such as...
-
March 1, 2005PREVIEW
In a small pilot study, initiating infliximab (Remicade—Centocor) with methotrexate early in the therapy of treatment-naive patients with rheumatoid arthritis (RA) led to a rapid decrease in...
-
January 1, 2005PREVIEW
Bisphosphonates can prevent the osteoporosis that can develop in women being treated for breast cancer with bone-depleting hormonal agents. Researchers are also finding that the drugs can help...
-
October 1, 2004PREVIEW
In what is likely the largest drug recall ever in terms of sales, Merck announced on September 30 a worldwide, voluntary withdrawal of Vioxx, its brand of rofecoxib. The action was prompted by...
Pages
